Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anxiety Disorders × N-Methyl-3,4-methylenedioxyamphetamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Anxiety Disorders 1 Adjustment Disorders 1

Interventions

Psilocybin 4 Psychotherapy 2 Fluoxetine 2 Cannabidiol 2 nabiximols 1 Yoga 1 Therapeutics 1 Sertraline 1 Selective Serotonin Reuptake Inhibitors 1 Pharmaceutical Preparations 1 Niacin 1 Neoadjuvant Therapy 1 N-Methyl-3,4-methylenedioxyamphetamine 1 Minocycline 1 Medical Marijuana 1 Ketamine 1 Injections 1 Hormones 1 Gemcitabine 1 Dronabinol 1 Donepezil 1 Citalopram 1 Cisplatin 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00252174 2017-11-14

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

Brigham and Women's Hospital

Phase 2 Terminated

2 enrolled 6 charts

Anxiety Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡